Peter A. Schwartz

Peter Schwartz is a partner in our New York office who focuses on mergers and acquisitions, private equity and corporate finance.  His M&A and private equity experience includes leveraged buy-outs, public and private acquisitions and divestitures and minority investments.  His corporate finance experience includes a wide range of financing activities, including acquisition finance, secured and unsecured syndicated credit facilities, high yield offerings and restructurings.

Representative Matters

M&A and Private Equity

• Represented Pfizer in its acquisitions of Coley Pharmaceuticals and Serenex.
• Represented Procter & Gamble in the sale of its ThermaCare Heatwraps business and the pending sale of its Noxzema business.
• Represented Perseus, L.L.C. in its sale of Maritime Telecommunications Network (The M&A Advisor US Middle-Market Deal of the Year); in its investment in The Vehicle Production Group; as the lead equity sponsor in the leveraged buy-out of Haggar Corp.; and in the equity and debt financing for the acquisition of the Relizon Company. 
• Represented the founders of Carrentals.com in the sale of their company to Expedia.
• Represented Johnson & Johnson in its acquisition of Transform Pharmaceuticals.
• Represented Thomson Reuters on the sales of its American Health Consultants business unit and a portfolio of healthcare magazines and journals.
• Represented Charlesbank Capital Partners and Penske Capital Partners in their investment in Universal Technical Institute and subsequent exit of the investment via IPO and secondary offerings.
• Represented UBS in its acquisition of Enron’s gas and power trading business, including its Enron Online trading platform.
• Represented IAC/InterActiveCorp in its acquisition of Interval International. 

• Represented The Goodyear Tire & Rubber Company in its $3.3 billion global debt restructuring and subsequent financings and refinancings, including first, second and third lien credit facilities, secured and unsecured high yield bonds, a pan-European accounts receivable securitization and a synthetic letter of credit facility.
• Represented Kerr-McGee Corporation in a $5.5 billion multi-tranche senior secured credit facility to finance an equity tender offer driven by a proxy contest with Carl Ichan and a subsequent $1.25 billion unsecured revolving credit facility.
• Represented Paramount Acquisition Corp., a healthcare focused special purpose acquisition company (SPAC) in the first and second lien debt financing for its acquisition of ChemRx.
• Represented Touch Tunes Music Corporation in a number of equity and secured and unsecured debt financings.
• Represented Centre Solutions in a loan to Royalty Pharma, secured by a portfolio of pharmaceutical royalties.
• Represented Calpine Corporation in a nonrecourse financing secured by two power plants.
• Represented Microsoft in repurchase agreements to finance a $30 billion dividend payment and its $20 billion stock self-tender.

Honors and Rankings

• Legal 500 US, Private Equity Buyouts - Middle Market (2008)

Publications and Speeches

• "Redefining Market Terms," PEI Manager (February 2008), Co-Author
• "Covenant Negotiation Considerations and Compliance Best Practices," Association for Finance Professionals Annual Conference (2007)